HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
New Zealand Health Drug Safety

OTC Pholcodine Ban Coming To New Zealand

  • News

Executive Summary

New Zealand will likely be the next country to ban sales of popular OTC dry cough treatment pholcodine following a safety alert issued by the World Health Organization.

You may also be interested in...



Pholcodine Alert Goes Global As WHO Warns Against Use

The World Health Organization has issued a safety alert warning regulators around the world about the potential dangers of pholcodine use following the withdrawal of the cough treatment in Europe and elsewhere.

National Regulators Back European Pholcodine Ban

By majority vote, the Heads of Medicines Agencies' CMDh has agreed to withdraw the marketing authorizations for all drugs containing pholcodine sold in the EU and European Economic Area countries.

Nestlé Partner Valbiotis Hails Trial Results For Prediabetes Supplement

Valbiotis and Nestlé Health Science plan to launch in 2024 a dietary supplement targeted at sufferers of prediabetes and type-2 diabetes following positive results from a recent study which showed the product's efficacy on key markers of glucose metabolism.

Table

View full table

Topics

Tags:
New Zealand Health Drug Safety
Latest Headlines

Arcaea Resurrects Extinct Flowers With First Fragrances Under Future Society Brand; Cosmetics News

Message Clear For Xylitol Nasal Spray Firm Xlear: ‘Capitalize’ On FDA’s Oral Phenylephrine Doubts

Why Are UK CBD Brands Pivoting Into Functional Mushroom Supplements?

Haleon Helps Pharmacists #ListentoPain As Social Stigma And Isolation Increases

See All
UsernamePublicRestriction

Register

RS154001

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By